DY
TCON
Dowling & Yahnke’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $79K | Hold |
47,455
| – | – | ﹤0.01% | 365 |
|
|
2022
Q2 | $95K | Hold |
47,455
| – | – | ﹤0.01% | 367 |
|
|
2022
Q1 | $125K | Hold |
47,455
| – | – | 0.01% | 368 |
|
|
2021
Q4 | $131K | Buy |
47,455
+7,000
| +17% | +$19.3K | 0.01% | 368 |
|
|
2021
Q3 | $157K | Hold |
40,455
| – | – | 0.01% | 364 |
|
|
2021
Q2 | $263K | Hold |
40,455
| – | – | 0.02% | 322 |
|
|
2021
Q1 | $333K | Buy |
40,455
+10,000
| +33% | +$82.3K | 0.02% | 281 |
|
|
2020
Q4 | $356K | Hold |
30,455
| – | – | 0.03% | 271 |
|
|
2020
Q3 | $157K | Buy |
30,455
+10,000
| +49% | +$51.6K | 0.01% | 298 |
|
|
2020
Q2 | $40K | Buy |
20,455
+5,455
| +36% | +$10.7K | ﹤0.01% | 291 |
|
|
2020
Q1 | $26K | Buy |
+15,000
| New | +$26K | ﹤0.01% | 287 |
|